Structural features of prions explored by sequence analysis. II. A PrPSc model

Cellular and Molecular Life Sciences

Volumn 59, Issue 12, 2002, Pages 2144-2154

  Mornon, J P ^a   Prat, K ^a   Dupuis, F ^a   Boisset, N ^a   Callebaut, I ^a  

^a SORBONNE UNIVERSITÉ   (France)

Author keywords

Cystatin; Fusion peptide; HCA; Prion; Swapping; TATA box binding protein; Ure2p

Indexed keywords

BINDING PROTEIN; PRION PROTEIN;

ALPHA HELIX; ARTICLE; DEGENERATIVE DISEASE; EXPERIMENTAL MODEL; HUMAN; HYPOTHESIS; PRION; PRION DISEASE; PROTEIN ANALYSIS; PROTEIN DOMAIN; PROTEIN FOLDING; PROTEIN STRUCTURE; SEQUENCE ANALYSIS; STRUCTURE ANALYSIS; TATA BOX;

AMINO ACID SEQUENCE; ANIMALS; DIMERIZATION; HUMANS; MICE; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; PRIONS; PROTEIN CONFORMATION; PROTEIN FOLDING; PROTEIN STRUCTURE, QUATERNARY; PROTEIN STRUCTURE, SECONDARY; PROTEIN STRUCTURE, TERTIARY; PRPSC PROTEINS; SACCHAROMYCES CEREVISIAE PROTEINS; SEQUENCE ANALYSIS, PROTEIN;

ANIMALIA;

EID: 0036971226     PISSN: 1420682X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s000180200014     Document Type: Article

References (61)

1. Prusiner S. B. (1998) Prions. Proc. Natl. Acad. Sci. USA 95: 13363-13383
2. Wopfner F., Weidenhöfer G., Schneider R., Von Brunn A., Gilch S., Schwarz T. F. et al. (1999) Analysis of 27 mammalian and 9 avian PrPs reveals high conservation of flexible regions of the prion protein. J. Mol. Biol. 289: 1163-1178
3. Westaway D. and Carlson G. A. (2002) Mammalian prion proteins: enigma, variation and vaccination. Trends Biochem. Sci. 27:301-307
4. Riek R., Hornemann S., Wider G., Billeter M., Glockshuber R. and Wüthrich K. (1996) NMR structure of the mouse prion protein domain PrP (121-321). Nature 382: 180-182
5. Riek R., Hornemann S., Wider G., Glockshuber R. and Wüthrich K. (1997) NMR characterization of the full-length recombinant murine prion protein, mPrP (23-231). FEBS Lett. 413:282-288
6. Zahn R., Liu A., Luhrs T., Riek R., Schroetter C. von, Lopez Garcia F. et al. (2000) NMR solution structure of the human prion protein. Proc. Natl. Acad. Sci. USA 97: 145-150
7. Knaus K. J., Morillas M., Swietnicki W., Malone M., Surewicz W. K. and Yee V. C. (2001) Crystal structure of the human prion protein reveals a mechanism for oligomerization. Nat. Struct. Biol. 8: 770-774
8. Mo H., Moore R. C., Cohen F. E., Westaway D., Prusiner S. B., Wright P. E. et al. (2001) Two different neurodegenerative diseases caused by proteins with similar structures. Proc. Natl. Acad. Sci. USA 98: 2352-2357
9. Bousset L., Belrhali H., Janin J., Melki R. and Morera S. (2001) Structure of the globular region of the prion protein Ure2 from the yeast Saccharomyces cerevisiae. Structure 9: 39-46
10. Umland T. C., Taylor K. L., Rhee S., Wickner R. B. and Davies D. R. (2001) The crystal structure of the nitrogen regulation fragment of the yeast prion protein Ure2p. Proc. Natl. Acad. Sci. USA 98: 1459-1464
11. Gaboriaud C., Bissery V., Benchetrit T. and Mornon J. P. (1987) Hydrophobic cluster analysis: an efficient new way to compare and analyse amino acid sequences. FEBS Lett. 224: 149-155
12. Callebaut I., Labesse G., Durand P., Poupon A., Canard L., Chomilier J. et al. (1997) Deciphering protein sequence information through hydrophobic cluster analysis (HCA): current status and perspectives. Cell. Mol. Life Sci. 53: 621-645
13. Mornon J., Prat K., Dupuis F. and Callebaut I. (2002) Structural features of prions explored by sequence analysis. I. Sequence data. Cell. Mol. Life Sci. 59: 1366-1376
14. Wille H., Michelitsch M. D., Guenebaut V., Supattapone S., Serban A., Cohen F. E. et al. (2002) Structural studies of the scrapie prion protein by electron crystallography. Proc. Natl. Acad. Sci. USA 99: 3563-3568
15. Berman H. M., Westbrook J., Feng Z., Gilliland G., Bhat T. N., Weissig H. et al. (2000) The Protein Data Bank. Nucleic Acids Res. 28: 235-242
16. Guex N. and Peitsch M. C. (1997) SWISS-MODEL and the Swiss-Pdb Viewer: an environment for comparative protein modeling. Electrophoresis 18: 2714-2723
17. Kaplan W. and Littlejohn T. G. (2001) Swiss-PDB Viewer (Deep View). Brief Bioinform. 2: 195-197
18. Nikolov D. B., Chen H., Halay E. D., Hoffman A., Roeder R. G. and Burley S. K. (1996) Crystal structure of a human TATA box-binding protein/TATA element complex. Proc. Natl. Acad. Sci. USA 93: 4862-4867
19. Blake C. C. F., Geisow M. J., Oatley S. J., Rérat B. and Rérat C. (1978) Structure of prealbumin: secondary, tertiary and quaternary interactions determined by Fourier refinement at 1.8 Å. J. Mol. Biol. 121: 339-356
20. Liu S. and Eisenberg D. (2002) 3D domain swapping: as domains continue to swap. Protein Sci. 11: 1285-1299
21. Gilis D. and Rooman M. (2000) PoPMuSiC, an algorithm for predicting protein mutant stability changes: application to prion proteins. Protein Eng. 13: 849-856
22. Hosszu L. L. P., Baxter N. J., Jackson G. S., Power A., Clarke A. R., Waltho J. P. et al. (1999) Structural mobility of the human prion protein probed by backbone hydrogen exchange. Nat. Struct. Biol. 6: 740-743
23. C to form β sheet using NMR structures and sequence alignments. Biophys. J. 83: 1268-1280
24. Karlberg Y., Gustafsson M., Persson B., Thyberg J. and Johansson J. (2001) Prediction of amyloid fibril-forming proteins. J. Biol. Chem. 276: 12945-12950
25. Sc? Biochemistry 41: 12277-12283
26. Peretz D., Williamson R. A., Matsunaga Y., Serban H., Pinilla C., Bastidas R. B. et al. (1997) A conformational transition at the N terminus of the prion protein features in formation of the scrapie isoform. J. Mol. Biol. 273: 614-622
27. Williamson R. A., Peretz D., Pinilla C., Ball H., Bastidas R. B., Rozenshteyn R. et al. (1998) Mapping the prion protein using recombinant antibodies. J. Virol. 72: 9413-9418
28. Callebaut I., Tasso A., Brasseur R., Burny A., Portetelle D. and Mornon J. P. (1994) Common prevalence of alanine and glycine in mobile reactive centre loops of serpins and viral fusion peptides: do prions possess a fusion peptide? J. Comput. Aided Mol. Des. 8: 175-191
29. Welker E., Raymond L. D., Scheraga H. A. and Caughey B. (2002) Intramolecular versus intermolecular disulfide bonds in prion proteins. J. Biol. Chem. 277: 33477-33481
30. Welker E., Wedemeyer W. J. and Scheraga H. A. (2001) A role for intermolecular disulfide bonds in prion diseases? Proc. Natl. Acad. Sci. USA 98: 4334-4336
31. Prusiner S. B. and Scott M. R. (1997) Genetics of prions. Annu. Rev. Genet. 286: 593-606
32. Caughey B. (2001) Interactions between prion protein isoforms: the kiss of death? Trends Biochem. Sci. 26: 235-242
33. Tompa P., Tusnady G. E., Friedrich P. and Simon I. (2002) The role of dimerization in prion replication. Biophys. J. 82: 1711-1718
34. Serpell L. C., Sunde M. and Blake C. C. F. (1997) The molecular basis of amyloidosis. Cell. Mol. Life Sci. 53: 871-887
35. Janowski R., Kozak M., Jankowska E., Grzonka Z., Grubb A., Abrahamson M. et al. (2001) Human cystatin C, an amyloidogenic protein, dimerizes through three-dimensional domain swapping. Nat. Struct. Biol. 8: 316-320
36. Staniforth R. A., Giannini S., Higgins L. D., Conroy M. J., Hounslow A. M., Jerala R. et al. (2001) Three-dimensional domain swapping in the folded and molten globule states of cystatins, an amyloid-forming structural superfamily. EMBO J. 20: 4774-4781
37. Huang Z., Prusiner S. B. and Cohen F. E. (1995) Scrapie prions: a three-dimensional model of an infectious fragment. Fold Des. 1: 13-19
38. Warwicker J. (2000) Modeling a prion protein dimer: predictions for fibril formation. Biochem. Biophys. Res. Commun. 278: 646-652
39. Nicholson E. M., Mo H., Prusiner S. B., Cohen F. E. and Marqusee S. (2002) Differences between the prion protein and its homolog Doppel: a partially structured state with implications for scrapie formation. J. Mol. Biol. 316: 807-815
40. Blake C. and Serpell L. (1996) Synchrotron X-ray studies suggest that the core of the transthyretin amyloid fibril is a continuous beta-sheet helix. Structure 4: 989-998
41. Jamin N., Coïc Y.-M., Landon C., Ovtracht L., Baleux F., Neumann J.-M. et al. (2002) Most of the structural elements of the globular domain of murine prion protein form fibrils with predominant β-sheet structure. FEBS Lett. 529: 256-260
42. Bousset L., Belrhali H., Melki R. and Morera S. (2001) Crystal structures of the yeast prion Ure2p functional region in complex with glutathione and related compounds. Biochemistry 40: 13564-13573
43. Bousset L., Thomson N. H., Radford S. E. and Melki R. (2002) The yeast prion Ure2p retains its native α-helical conformation upon assembly into protein fibrils in vitro. EMBO J. 21: 2903-2911
44. Schlumpberger M., Wille H., Baldwin M. A., Butler D. A., Herskowitz I. and Prusiner S. B. (2000) The prion domain of yeast Ure2p induces autocatalytic formation of amyloid fibers by a recombinant fusion protein. Protein Sci. 9: 440-451
45. Gabus C., Auxilien S., Pechoux C., Dormont D., Swietnicki W., Morillas M. et al. (2001) The prion protein has DNA strand transfer properties similar to retroviral nucleocapsid protein. J. Mol. Biol. 307: 1011-1021
46. Gabus C., Derrington E., Leblanc P., Chnaiderman J., Dormont D., Swietnicki W. et al. (2001) The prion protein has RNA binding and chaperoning properties characteristic of nucleocapsid protein NCP7 of HIV- 1. J. Biol. Chem. 276: 19301-19309
47. Cordeiro Y., Machado F., Neto L. J., Juliano M. A., Brentani R. R., Foguel D. et al. (2001) DNA converts cellular prion protein into the β-sheet conformation and inhibits prion peptide aggregation. J. Biol. Chem. 276: 49400-49409
48. Nandi P. K., Leclerc E., Nicole J.-C. and Takahashi M. (2002) DNA-induced partial unfolding of prion protein leads to its polymerisation to amyloid. J. Mol. Biol. 322: 153-161
49. Salmona M., Malesani P., De Gioia L., Gorla S., Bruschi M., Molinari A. et al. (1999) Molecular determinants of the physicochemical properties of a critical prion protein region comprising residues 106-126. Biochem. J. 342: 207-214
50. Levy Y., Hanan E., Solomon B. and Becker O. M. (2001) Helix-coil transition of Pr 106-126: molecular dynamic study. Proteins 45: 382-396
51. Sanghera N. and Pinheiro T. J. T. (2002) Binding of prion protein to lipid membranes and implications for prion conversion. J. Mol. Biol. 315: 1241-1256
52. Sc) into contiguous membrane. EMBO J. 21: 1031-1040
53. Pillot T., Drouet B., Pincon-Raymond M., Vandekerckhove J., Rosseneu M. and Chambaz J. (2000) A nonfibrillar form of the fusogenic prion protein fragment [118-135] induces apoptotic cell death in rat conical neurons. J. Neurochem. 75: 2298-2308
54. Tompa P., Tusnady G. E., Cserko M. and Simon I. (2001) Prion protein: evolution caught en route. Proc. Natl. Acad. Sci. USA 98: 4431-4436
55. Chen S. G. (1995) Truncated forms of the human prion protein in normal brain and in prion diseases. J. Biol. Chem. 270: 19173-19180
56. Riek R., Wider G., Billeter M., Hornemann S., Glockshuber R. and Wüthrich K. (1998) Prion protein NMR structure and familial human spongiform encephalopathies. Proc. Natl. Acad. Sci. USA 95: 11667-11672
57. Zerovnik E. (2002) Amyloid-fibril formation: proposed mechanisms and relevance to conformational disease. Eur. J. Biochem. 269: 3362-3371
58. Smith C. J., Drake A. F., Banfield B. A., Bloomberg G. B., Palmer M. S., Clarke A. R. et al. (1997) Conformational properties of the prion octa-repeat and hydrophobic sequences. FEBS Lett. 405: 378-384
59. Merz P A., Somerville R. A., Wisniewski H. M., Manuelidis L. and Manuelidis E. E. (1983) Scrapie-associated fibrils in Creutzfeldt-Jakob disease. Nature 306: 474-476
60. Diringer H., Gelderblom H., Hilmert H., Özel M. and Edelbluth C. (1983) Scrapie infectivity, fibrils and low molecular weight protein. Nature 306: 476-478
61. Merz P. A., Rohwer R. G., Kascsak R., Wisniewski H. M., Somerville R. A., Gibbs C. J. et al. (1984) Infection-specific particle from the unconventional slow virus diseases. Science 225: 437-440